Osteoporosis is a skeletal disorder that causes impairment of bone structure and strength,
leading to a progressively increased risk of fragility fractures. The global prevalence of …

Postmenopausal osteoporosis (PMO) results from a reduction in bone mass and
microarchitectural deterioration in bone tissue due to estrogen deficiency, which may …

Clinically manifested resistance of bacteria to antibiotics has emerged as a global threat to
society and there is an urgent need for the development of novel classes of antibacterial …

The purpose of the present systematic review was to investigate the influence of
bisphosphonates (BPs) on the dental implant failure rate and marginal bone loss (MBL). An …

Fractures occur in about half of older White women, and almost a third of older White men.
However, 80% of the older individuals who have fractures do not meet the bone density …

Phosphonates and bisphosphonates are stable analogs of phosphates and pyrophosphates
that are characterized by one and two carbon–phosphorus bonds, respectively. Among the …

Improving local bone mineral density (BMD) at fracture‐prone sites of bone is a clinical
concern for osteoporotic fracture prevention. In this study, a featured radial extracorporeal …

Eradication of MRSA osteomyelitis requires elimination of distinct biofilms. To overcome this,
we developed bisphosphonate-conjugated sitafloxacin (BCS, BV600072) and …

Bone cancer is usually a metastatic disease, affecting people of all ages. Its effective therapy
requires a targeted drug administration locally at the cancer site so that the surrounding …

Metabolic reprogramming represents a hallmark of tumorigenesis to sustain survival in
harsh conditions, rapid growth and metastasis in order to resist to cancer therapies. These …